Andrea Crocker

1.2k total citations
19 papers, 878 citations indexed

About

Andrea Crocker is a scholar working on Immunology, Oncology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Andrea Crocker has authored 19 papers receiving a total of 878 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Immunology, 10 papers in Oncology and 7 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Andrea Crocker's work include Immunotherapy and Immune Responses (9 papers), Monoclonal and Polyclonal Antibodies Research (7 papers) and Cancer Immunotherapy and Biomarkers (7 papers). Andrea Crocker is often cited by papers focused on Immunotherapy and Immune Responses (9 papers), Monoclonal and Polyclonal Antibodies Research (7 papers) and Cancer Immunotherapy and Biomarkers (7 papers). Andrea Crocker collaborates with scholars based in United States, United Kingdom and Israel. Andrea Crocker's co-authors include Laura Vitale, Tibor Keler, Li-Zhen He, Lawrence J. Thomas, Raphael Clynes, Henry C. Marsh, Thomas A. Davis, Michael Yellin, Rachel E. Sanborn and Jose Lutzky and has published in prestigious journals such as Journal of Clinical Investigation, Journal of Clinical Oncology and Blood.

In The Last Decade

Andrea Crocker

18 papers receiving 856 citations

Peers

Countries citing papers authored by Andrea Crocker

Since Specialization

Citations

This map shows the geographic impact of Andrea Crocker's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andrea Crocker with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andrea Crocker more than expected).

Fields of papers citing papers by Andrea Crocker

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Andrea Crocker. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andrea Crocker. The network helps show where Andrea Crocker may publish in the future.

Co-authorship network of co-authors of Andrea Crocker

This figure shows the co-authorship network connecting the top 25 collaborators of Andrea Crocker. A scholar is included among the top collaborators of Andrea Crocker based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Andrea Crocker. Andrea Crocker is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

19 of 19 papers shown

#	Work	Indexed citations
1	Dual Inhibition of Mast Cells and Thymic Stromal Lymphopoietin Using a Novel Bispecific Antibody, CDX ‐622 2025 ·Allergy ·Miles Murphy, Laura Vitale, Thomas J. O’Neill, Deena M. Maurer, (unknown), Andrea Crocker, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Russell A. Hammond, J. Goldstein, Lawrence J. Thomas, Tibor Keler, (unknown)	2
2	Dual targeting of mast cells and TSLP with a bispecific antibody 2023 ·The Journal of Immunology ·Diego Alvarado, Laura Vitale, Michael Murphy, Anna Wasiuk, Jenifer Widger, Andrea Crocker, (unknown), (unknown), Thomas J. O’Neill, (unknown), (unknown), (unknown), (unknown), Jay S. Lillquist, (unknown), (unknown), J. Goldstein, Lawrence J. Thomas, Henry C. Marsh, Tibor Keler	1
3	Anti‐KIT monoclonal antibody CDX‐0159 induces profound and durable mast cell suppression in a healthy volunteer study 2022 ·Allergy ·Diego Alvarado, Marcus Maurer, Richard Gedrich, Scott B. Seibel, Michael Murphy, (unknown), J. Goldstein, Andrea Crocker, Laura Vitale, (unknown), Lawrence J. Thomas, Thomas Hawthorne, Tibor Keler, Diane Young, Elizabeth Crowley, Martin Kankam, Margo Heath‐Chiozzi	62
4	Conditioning treatment with CD27 Ab enhances expansion and antitumor activity of adoptively transferred T cells in mice 2021 ·Cancer Immunology Immunotherapy ·Anna Wasiuk, (unknown), (unknown), Jenifer Widger, Andrea Crocker, Laura Vitale, Henry C. Marsh, Tibor Keler, Li-Zhen He	4
5	Development of CDX-527: a bispecific antibody combining PD-1 blockade and CD27 costimulation for cancer immunotherapy 2020 ·Cancer Immunology Immunotherapy ·Laura Vitale, Li-Zhen He, Lawrence J. Thomas, Anna Wasiuk, Thomas J. O’Neill, Jenifer Widger, Andrea Crocker, (unknown), (unknown), (unknown), (unknown), Russell A. Hammond, (unknown), (unknown), Diego Alvarado, J. Goldstein, Henry C. Marsh, Tibor Keler	23
6	D100 CDX-0159, AN ANTI-KIT MONOCLONAL ANTIBODY, AS A MODULATOR OF MAST CELL-RELATED DISEASES 2019 ·Annals of Allergy Asthma & Immunology ·Scott B. Seibel, Laura Vitale, (unknown), J. Goldstein, (unknown), Andrea Crocker, (unknown), Christopher J. Patterson, (unknown), Russell A. Hammond, Tibor Keler, Richard Gedrich	1
7	Development of CDX-1140, an agonist CD40 antibody for cancer immunotherapy 2018 ·Cancer Immunology Immunotherapy ·Laura Vitale, Lawrence J. Thomas, Li-Zhen He, Thomas J. O’Neill, Jenifer Widger, Andrea Crocker, Karuna Sundarapandiyan, James R. Storey, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), J. Goldstein, Henry C. Marsh, Tibor Keler	39
8	CD27-Mediated Regulatory T Cell Depletion and Effector T Cell Costimulation Both Contribute to Antitumor Efficacy 2017 ·The Journal of Immunology ·Anna Wasiuk, James Testa, (unknown), (unknown), Laura Vitale, Jenifer Widger, Andrea Crocker, Lawrence J. Thomas, J. Goldstein, Henry C. Marsh, Tibor Keler, Li-Zhen He	40
9	Development of a Novel Antibody–Drug Conjugate for the Potential Treatment of Ovarian, Lung, and Renal Cell Carcinoma Expressing TIM-1 2016 ·Molecular Cancer Therapeutics ·Lawrence J. Thomas, Laura Vitale, Thomas J. O’Neill, (unknown), Paul K. Wallace, Hans Minderman, (unknown), (unknown), (unknown), James R. Storey, (unknown), Russell A. Hammond, Jenifer Widger, Karuna Sundarapandiyan, Andrea Crocker, Henry C. Marsh, Tibor Keler	34
10	A Phase II Randomized Study of CDX-1401, a Dendritic Cell Targeting NY-ESO-1 Vaccine, in Patients with Malignant Melanoma Pre-Treated with Recombinant CDX-301, a Recombinant Human Flt3 Ligand. 2016 ·Journal of Clinical Oncology ·Nina Bhardwaj, Anna C. Pavlick, Marc S. Ernstoff, Brent A. Hanks, Mark R. Albertini, Jason J. Luke, Michael Yellin, Tibor Keler, Thomas A. Davis, Andrea Crocker, Laura Vitale, Chihiro Morishima, Philip Friedlander, Martin A. Cheever, Steven P. Fling	18
11	CDX-1140, a Novel Agonist CD40 Antibody with Potent Anti-Lymphoma Activity 2016 ·Blood ·Li-Zhen He, James Testa, Anna Wasiuk, (unknown), (unknown), Laura Vitale, Thomas J. O’Neill, Andrea Crocker, Jenifer Widger, J. Goldstein, Henry C. Marsh, Tibor Keler	6
12	Abstract 4866: Development and characterization of novel CD40 antibody agonists for cancer immunotherapy 2016 ·Cancer Research ·Laura Vitale, Thomas J. O’Neill, Jenifer Widger, Andrea Crocker, Li-Zhen He, (unknown), Karuna Sundarapandiyan, James R. Storey, Lawrence J. Thomas, J. Goldstein, Henry C. Marsh, Tibor Keler	1
13	The mechanism of anti-tumor immunity induced by varlilumab, a CD27 agonist mAb, is model dependent 2015 ·Journal for ImmunoTherapy of Cancer ·Li-Zhen He, Anna Wasiuk, James Testa, (unknown), (unknown), Andrea Crocker, Jenifer Widger, (unknown), (unknown), Lawrence J. Thomas, Henry C. Marsh, Tibor Keler	2
14	Induction of Antigen-Specific Immunity with a Vaccine Targeting NY-ESO-1 to the Dendritic Cell Receptor DEC-205 2014 ·Science Translational Medicine ·Madhav V. Dhodapkar, Mario Sznol, Biwei Zhao, Ding Wang, Richard D. Carvajal, Mary Louise Keohan, Ellen Chuang, Rachel E. Sanborn, Jose Lutzky, John D. Powderly, Harriet M. Kluger, Sheela Tejwani, Jennifer Green, Venky Ramakrishna, Andrea Crocker, Laura Vitale, Michael Yellin, Thomas A. Davis, Tibor Keler	305
15	Agonist Anti-Human CD27 Monoclonal Antibody Induces T Cell Activation and Tumor Immunity in Human CD27–Transgenic Mice 2013 ·The Journal of Immunology ·Li-Zhen He, (unknown), Lawrence J. Thomas, Laura Vitale, (unknown), Andrea Crocker, (unknown), (unknown), Andrew Tutt, Martin J. Glennie, Henry C. Marsh, Tibor Keler	80
16	Development of a Human Monoclonal Antibody for Potential Therapy of CD27-Expressing Lymphoma and Leukemia 2012 ·Clinical Cancer Research ·Laura Vitale, (unknown), Lawrence J. Thomas, (unknown), (unknown), Andrea Crocker, Thomas J. O’Neill, James R. Storey, Martin J. Glennie, Deanna M. Grote, Stephen M. Ansell, Henry C. Marsh, Tibor Keler	53
17	Antibody-enhanced cross-presentation of self antigen breaks T cell tolerance 2007 ·Journal of Clinical Investigation ·(unknown), Andrea Crocker, Geoffrey Catalano, Vivette D. D’Agati, Steffen Jung, Dharmesh D. Desai, Raphael Clynes	94
18	Antigenic Targeting of the Human Mannose Receptor Induces Tumor Immunity 2007 ·The Journal of Immunology ·Li-Zhen He, Andrea Crocker, (unknown), (unknown), Xitao Wang, Laura Vitale, Thomas J. O’Neill, (unknown), Huifen Zhang, (unknown), Dan Rohrer, Tibor Keler, Raphael Clynes	112
19	Targeting antigens to the human mannose receptor expressed in transgenic mice elicits potent CD4 and CD8 responses in vivo 2006 ·Cancer Research ·Li-Zhen He, Andrea Crocker, Laura Vitale, Thomas J. O’Neill, Raphael Clynes, Tibor Keler	1

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact